David Goldsmith

Renal Unit, Guy's Hospital, United Kingdom

David Goldsmith

Academic positions:
- Consultant Nephrologist, Guy's Hospital
- Honorary Senior Lecturer at Guy's King's and St Thomas' Hospitals Medical School

All industry positions (in last five years):
None declared

Research interests:
- Arterial structural and functional changes seen in uraemia,
- The use of ambulatory blood pressure monitoring as a tool to improve BP management of renal patients
- The use of screening tools to detect the presence of cardiovascular disease in patients with renal failure
- Characterisation of abnormal purine and pyrimidine metabolism in renal patients.

Any other information:
Associations;
- Royal Society of Medicine
- London Hypertension Society
- Medical Society of London
- UK Renal Association
- International Society of Nephrology
- European Renal Association
- Medical Journalists Association

Dr Goldsmith acts as a regular reviewer for various journals including and is a member of the Editorial Board for Journal of Renovascular Disease (2002 - ) and Nephrology, Dialysis and Transplantation (2004 -) and also Editor of Nephrology, Dialysis, Transplantation–Educational (2003-) and the Journal of Nephrology (2003 -).

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Nephrology > Pathophysiology of Chronic Kidney Disease (CKD) (since 09 March 2006)

Links

http://www.dgoldsmith.co.uk

All recent recommendations

• 6.0
  Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
  Recommended by David Goldsmith
  
• 3.0
  Differential effects of rapamycin in anti-GBM glomerulonephritis.
  Recommended by David Goldsmith with Behdad Afzali
  
• 3.0
  Impaired immune responses and antigen-specific memory CD4+ T cells in hemodialysis patients.
  Recommended by David Goldsmith with Behdad Afzali
  
• 3.0
  Mortality Risk for Dialysis Patients With Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS).
  Recommended by David Goldsmith
  
• 3.0
  Design and validation of a model to predict early mortality in haemodialysis patients.
  Recommended by David Goldsmith with Behdad Afzali
  
• 3.0
  Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan.
  Recommended by David Goldsmith with Behdad Afzali
  
• 4.8
  Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis.
  Recommended by David Goldsmith with Behdad Afzali, Edgar Lerma
  
• 3.2
  Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study.
  Recommended by David Goldsmith with Dr Refik Gökmen, Kazuomi Kario with Joji Ishikawa
  
• 3.0
  Monocyte infiltration and kidney allograft dysfunction during acute rejection.
  Recommended by David Goldsmith with Behdad Afzali
  
• 3.0
  Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study.
  Recommended by David Goldsmith
  
• 3.0
  Estimating GFR using serum cystatin c alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD.
  Recommended by David Goldsmith
  
• 6.0
  Mechanism of increased mortality risk with erythropoietin treatment to higher hemoglobin targets.
  Recommended by David Goldsmith
  
• 3.0
  The practical implications of using standardized estimation equations in calculating the prevalence of chronic kidney disease.
  Recommended by David Goldsmith
  
• 3.0
  Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview.
  Recommended by David Goldsmith
  
• 3.0
  Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients.
  Recommended by David Goldsmith
  
• 3.0
  Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients.
  Recommended by David Goldsmith
  
• 4.9
  Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis.
  Recommended by David Goldsmith, Asok Antony, Jurg Schifferli
  Dissent by Giuseppe Remuzzi
• 3.0
  Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study.
  Recommended by David Goldsmith
  
• 3.0
  High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells.
  Recommended by David Goldsmith
  
• 3.0
  Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells.
  Recommended by David Goldsmith
  
• 3.0
  Vascular calcification and cardiovascular function in chronic kidney disease.
  Recommended by David Goldsmith
  
• 3.0
  ACE-inhibitor use and the long-term risk of renal failure in diabetes.
  Recommended by David Goldsmith
  
• 3.0
  Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study.
  Recommended by David Goldsmith